Abstract CT325: First in human study of JNJ-42756493, a potent pan fibroblast growth factor receptor (FGFR) inhibitor in patients with advanced solid tumorsRodrigo Dienstmann,Rastilav Bahleda,Barbara Adamo,Jordi Rodon,Andrea Varga,Anas Gazzah,Suso Platero,Hans Smit,Timothy Perera,Bob Zhong,Kim Stuyckens,Yusri Elsayed,Chris Takimoto,Vijay Peddareddigari,Josep Tabernero, Feng Roger Luo,Jean-Charles SoriaClinical Trials（2014）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
